Overview Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model Status: Recruiting Trial end date: 2022-11-01 Target enrollment: Participant gender: Summary This study will assess the safety and antiviral activity of AT-752 in healthy subjects in a Dengue Human Challenge Model Phase: Phase 1 Details Lead Sponsor: Atea Pharmaceuticals, Inc.